NeuroMetrix Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Johns

WOBURN, Mass., April 23, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2020.  The Company is a.

NEW YORK, NY / ACCESSWIRE / April 23, 2020 / NeuroMetrix, Inc. (NASDAQ:NURO) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on April 23, 2020 at 8:00 AM

Apr 20, 2020 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" The "Feed Prebiotics Market" research...

Gainers Surgery Partners, Inc. (NASDAQ: SGRY) shares climbed 47.5% to close at $9.60. Taronis Technologies, Inc. (NASDAQ: TRNX) shares jumped 47% to close at $0.3382 on Friday...

Biotech stocks staged a nice recovery along with the broader markets in the week ended April 17.Apart from the broader market sentiment, big moves in biopharma companies such as Johnson & Johnson (NYS

NeuroMetrix, Inc. (NURO) today announced that Quell technology has been selected for use in a large, NIH-funded, randomized, pragmatic clinical trial of TENS for fibromyalgia. Fibromyalgia is a disor

NeuroMetrix, Inc. (NURO) announced today that it plans to issue its 2020 first quarter financial results before the opening of the market on Thursday, April 23, 2020. The Company will host a conferen

Edison Nation (NASDAQ:EDNT) +169% on over $10M order.Soligenix (NASDAQ:SNGX) +91% on deal for COVID-19 vaccine adjuvant.Atossa Therapeutics (NASDAQ:ATOS) +82% on launching COVID-19 HOPE drug devel

If you're interested in NeuroMetrix, Inc. (NASDAQ:NURO), then you might want to consider its beta (a measure of share...